Cleared Traditional

RayCare (2024A SP1) (K242992) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K242992 · RaySearch Laboratories AB (PUBL) · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2025
Decision
203d
Days
Class 2
Risk

K242992 is an FDA 510(k) clearance for the RayCare (2024A SP1). Classified as System, Planning, Radiation Therapy Treatment (product code MUJ), Class II - Special Controls.

Submitted by RaySearch Laboratories AB (PUBL) (Stockholm, SE). The FDA issued a Cleared decision on April 17, 2025 after a review of 203 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all RaySearch Laboratories AB (PUBL) devices

Submission Details

510(k) Number K242992 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 26, 2024
Decision Date April 17, 2025
Days to Decision 203 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
96d slower than avg
Panel avg: 107d · This submission: 203d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MUJ System, Planning, Radiation Therapy Treatment
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - MUJ System, Planning, Radiation Therapy Treatment

All 113
Devices cleared under the same product code (MUJ) and FDA review panel - the closest regulatory comparables to K242992.
PlanOne 1
K250963 · Cosylab Jsc, Control System Laboratory · Nov 2025
Dose+ (1.0)
K250064 · Mvision AI OY · Sep 2025
RT Elements (4.5)
K250440 · Brainlab AG · Jun 2025
Oncospace
K242748 · Oncospace, Inc. · Apr 2025
RayStation 2023B, RayPlan 2023B, RayStation 2024A, RayPlan 2024A, RayStation 2024A SP3, RayPlan 2024A SP3
K240398 · RaySearch Laboratories AB (PUBL) · Apr 2025
ART-Plan+ (v.3.0.0)
K242822 · Therapanacea Sas · Feb 2025